Literature DB >> 7317116

Central nervous system involvement in childhood systemic lupus erythematosus.

C L Yancey, R A Doughty, B H Athreya.   

Abstract

The records of 37 patients with systemic lupus erythematosus (SLE) followed at The Children's Hospital of Philadelphia between 1968 and 1978 were reviewed for evidence of central nervous system (CNS) involvement. Criteria for CNS involvement included evidence of organic brain syndrome, electroencephalographic abnormalities with symptoms referable to CNS, or objective neurologic signs. Sixteen of 37 children had CNS involvement (43%). Thirteen patients had CNS involvement at the onset of SLE. Three patients had late onset CNS manifestations 1 to 2 years after the diagnosis of SLE. The most frequently observed symptoms were headache, behavior disorder, lethargy, diplopia, blurred vision, memory alteration, dizziness, and alteration of consciousness. The most frequently observed neurologic signs were seizures, cranial nerve palsy, ataxia, papilledema, nystagmus, meningitis, tremor, rigidity, cortical blindness, and coma. Neuropsychiatric manifestations included organic brain syndrome, functional psychosis, and personality disorder. Laboratory tests showed elevated cerebrospinal fluid opening pressure and protein, negative cultures, and abnormal electroencephalograms and computerized axial tomography scans. Fourteen of 16 children with CNS manifestations are alive. Thirteen had a mean IQ of 89 by the Wechsler Intelligence Tests. Twelve are in educational programs. One required long-term psychiatric care. A residual neurologic abnormality, a seizure disorder, was present in 3. CNS involvement with SLE in children carries a favorable prognosis.

Entities:  

Mesh:

Year:  1981        PMID: 7317116     DOI: 10.1002/art.1780241109

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  Central nervous system manifestations after steroid pulse therapy in systemic lupus erythematosus.

Authors:  Yuichi Tabata; Kobayashi Ichiro; Nobuaki Kawamura; Motohiko Okano; Kunihiko Kobayashi
Journal:  Eur J Pediatr       Date:  2002-09       Impact factor: 3.183

Review 2.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

3.  Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Marisa S Klein-Gitelman; Frank Zelko; Erin C Thomas; Jessica Hummel; Shannen M Nelson; Jennifer Huggins; Megan L Curran; Tresa Roebuck-Spencer; Dean W Beebe; Jun Ying
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

4.  Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.

Authors:  Tricia S Williams; Cynthia Aranow; Gail S Ross; Alexandra Barsdorf; Lisa F Imundo; Andrew H Eichenfield; Philip J Kahn; Betty Diamond; Deborah M Levy
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

5.  Cerebral systemic lupus erythematosus.

Authors:  J King; A Aukett; M F Smith; G Hosking; A M Ward; P Hughes
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 6.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

7.  Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.

Authors:  J Font; R Cervera; G Espinosa; L Pallarés; M Ramos-Casals; S Jiménez; M García-Carrasco; L Seisdedos; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

8.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.

Authors:  Mohamed O Olfat; Sulaiman M Al-Mayouf; Mohamed A Muzaffer
Journal:  Clin Rheumatol       Date:  2004-07-23       Impact factor: 2.980

9.  Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus.

Authors:  A A Long; S D Denburg; R M Carbotte; D P Singal; J A Denburg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

10.  Clinical and serological spectrum of systemic lupus erythematosus in Greek children.

Authors:  A Siamopoulou-Mavridou; A K Mavridis; G Dimou; A A Drosos
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.